DNA X, Inc.
SONM
Rank in Stocks
#31329
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in... DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a broad international footprint, encompassing the United States, Canada, Europe, the Middle East, and the Asia-Pacific region. Their product portfolio includes a comprehensive range of ruggedized communication devices tailored for frontline and task workers. This lineup features models such as the Sonim XP10, Sonim XP5plus, Sonim XP3plus, Sonim XP Pro, as well as the XP100 4G and XP400 5G professional rugged phones, XP Pro 5G rugged smartphones, and XP3plus 5G rugged flip phones. Beyond handsets, DNA X, Inc. also provides connected solutions, offering both fixed wireless access and mobile hotspot devices. These include the Sonim H100 low- and mid-range mobile hotspots, the Sonim H700, and the advanced Sonim H500-series of 5G mobile hotspots. Complementing its hardware offerings, the company supplies proprietary SonimWare software and a selection of industrial-grade accessories. DNA X, Inc. distributes its products through a diverse network that includes wireless carriers, data device distributors, communications system integrators, and electronics resellers. The company's clientele spans various critical industries, including transportation and logistics, construction, manufacturing, facilities management, energy and utilities, mining, federal government agencies, and public safety organizations.
Share Price
$2.22
Last synced: 2026-11-09
Market Cap
$3.30M
Change (1 day)
4.23%
Change (1 year)
-79.95%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DNA X, Inc. (SONM)
Category
Technology
EPS for DNA X, Inc. (SONM)
EPS as of June 2026 TTM: $-1.27
According to DNA X, Inc.'s latest financial reports, its current EPS (TTM) is $-1.27. At the end of 2025 the company had an EPS of $-28.58, an increase over its 2024 EPS of $-128.37.
EPS history for DNA X, Inc. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.27 | -95.56% |
| 2025 | $-28.58 | -77.74% |
| 2024 | $-128.37 | 32,815.38% |
| 2023 | $-0.39 | -99.56% |
| 2022 | $-87.77 | -88.05% |
| 2021 | $-734.62 | -36.99% |
| 2020 | $-1.17K | -53.35% |
| 2019 | $-2.50K | 213.18% |
| 2018 | $-798.14 | -42.20% |
| 2017 | $-1.38K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.36 | -364.57% |
US
|
|
| $0.40 | -131.77% |
CN
|
|
| $12.56 | -1,088.98% |
US
|
|
| $3.45 | -371.68% |
CN
|
|
| $-89.12 | 6,917.32% |
US
|
Questions about DNA X, Inc.'s earnings per share (EPS)
What is DNA X, Inc.'s earnings per share (EPS)?
DNA X, Inc.'s earnings per share (EPS) over the last twelve months is $-1.27, as of Jun 2026.
What was DNA X, Inc.'s earnings per share (EPS) in 2025?
In 2025, DNA X, Inc.'s earnings per share (EPS) was $-28.58, compared with $-128.37 in 2024.
How has DNA X, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, DNA X, Inc.'s earnings per share (EPS) was highest in 2023 ($-0.39) and lowest in 2020 ($-1.17K).
How does DNA X, Inc.'s earnings per share (EPS) compare with similar companies?
DNA X, Inc.'s earnings per share (EPS) ($-1.27) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Motorola Solutions, Inc., with $12.56.